Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yuka Fujita
Survival Analysis for Patients With ALK Rearrangement‐Positive Non‐Small Cell Lung Cancer and a Poor Performance Status Treated With Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401
Oncologist
Cancer Research
Medicine
Oncology
Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702)
Oncologist
Cancer Research
Medicine
Oncology
Related publications
Economic Impact of Preventing Brain Metastases With Alectinib in ALK-positive Non-Small Cell Lung Cancer
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
How Should We Treat Alectinib-Refractory ALK-Positive Non–Small Cell Lung Cancer?
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Alectinib in ALK -Positive, Crizotinib-Resistant, Non-Small-Cell Lung Cancer: A Single-Group, Multicentre, Phase 2 Trial
The Lancet Oncology
Oncology
Chinese Perspectives on Clinical Efficacy and Safety of Alectinib in Patients With ALK-positive Advanced Non-Small Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Clinical Analysis of EGFR‐ Positive Non‐small Cell Lung Cancer Patients Treated With First‐line Afatinib: A Nagano Lung Cancer Research Group
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Case Report of Non-Small Cell Lung Cancer With STRN-ALK Translocation: A Nonresponder to Alectinib
Journal of Nihon University Medical Association
A Case Report of an EML4-ALK-positive Elderly Non-Small Cell Lung Cancer Patient With a Poor PS Successfully Treated With Crizotinib
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Treating Patients With ALK-positive Non-Small Cell Lung Cancer: Latest Evidence and Management Strategy
Therapeutic Advances in Medical Oncology
Oncology
Fever and Survival With Drug-Treated Non-Small Cell Lung Cancer.
Kurume Medical Journal
Medicine
